Epidemiology of arrhythmias and sudden cardiac death in Asia

Circulation Journal

Volumn 77, Issue 10, 2013, Pages 2419-2431

  Murakoshi, Nobuyuki ^a   Aonuma, Kazutaka ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Arrhythmia; Atrial fibrillation; Epidemiology; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MEXILETINE;

ARTICLE; ASIA; BRADYCARDIA; BRUGADA SYNDROME; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CEREBROVASCULAR ACCIDENT; ELECTROCARDIOGRAPHY; GENE MUTATION; GENETIC ASSOCIATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; LONG QT SYNDROME; META ANALYSIS (TOPIC); PREVALENCE; RISK FACTOR; SHORT QT SYNDROME; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUT-OF-HOSPITAL CARDIAC ARREST;

EID: 84884647073     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1129     Document Type: Article

References (109)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention. The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370-2375.
2. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study: The Rotterdam study. Stroke 1997; 28: 316-321.
3. Jeong JH. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci 2005; 20: 26-30.
4. Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the chinese population of mainland China. J Epidemiol 2008; 18: 209-216.
5. Yap KB, Ng TP, Ong HY. Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: A population-based study. J Electrocardiol 2008; 41: 94-98.
6. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol 2009; 137: 102-107.
7. Chien KL, Su TC, Hsu HC, Chang WT, Chen PC, Chen MF, et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int J Cardiol 2010; 139: 173-180.
8. Shen AYJ, Contreras R, Sobnosky S, Shah AI, Ichiuji AM, Jorgensen MB, et al. Racial/ethnic differences in the prevalence of atrial fibril-lation among older adults: A cross-sectional study. J Natl Med Assoc 2010; 102: 906-913.
9. Ohsawa M, Okayama A, Okamura T, Itai K, Nakamura M, Tanno K, et al. Mortality risk attributable to atrial fibrillation in middle-aged and elderly people in the Japanese general population: Nineteen-year follow-up in NIPPON DATA80. Circ J 2007; 71: 814-819.
10. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE. The natural-history of atrial-fibrillation: Incidence, risk-factors, and prognosis in the Manitoba follow-up-study. Am J Med 1995; 98: 476-484.
11. Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: A report from the J-RHYTHM Registry. Circ J 2011; 75: 1328-1333.
12. Benjamin EJ, Levy D, Vaziri SM, Dagostino RB, Belanger AJ, Wolf PA. Independent risk-factors for atrial-fibrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994; 271: 840-844.
13. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fibrillation: The Niigata Preventive Medicine Study. Circulation 2008; 117: 1255-1260.
14. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
15. Wang TJ, Parise H, Levy D, Dagostino RB, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004; 292: 2471-2477.
16. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001; 142: 838-842.
17. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Infammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.
18. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110: 364-367.
19. Horio T, Iwashima Y, Kamide K, Tokudome T, Nakata H, Yoshihara F, et al. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in patients with essential hypertension. Circulation 2008; 118: S727-S728.
20. Fukunami M, Yamada T, Ohmori M, Kumagai K, Umemoto K, Sakai A, et al. Detection of patients at risk for paroxysmal atrial-fibrillation during sinus rhythm by P-wave triggered signal-averaged electrocardiogram. Circulation 1991; 83: 162-169.
21. Guidera SA, Steinberg JS. The signal-averaged P-wave duration: A rapid and noninvasive marker of risk of atrial-fibrillation. J Am Coll Cardiol 1993; 21: 1645-1651.
22. Watanabe H, Tanabe N, Makiyama Y, Chopra SS, Okura Y, Suzuki H, et al. ST-segment abnormalities and premature complexes are predictors of new-onset atrial fibrillation: The Niigata Preventive Medicine Study. Am Heart J 2006; 152: 731-735.
23. Binici Z, Intzilakis T, Nielsen OW, Kober L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibril-lation and stroke. Circulation 2010; 121: 1904-1911.
24. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: The Framingham Heart Study. Circulation 1994; 89: 724-730.
25. Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40: 1636-1644.
26. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis identifes six new susceptibility loci for atrial fibrillation. Nat Genet 2012; 44: 670-675.
27. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. Circulation 1998; 98: 946-952.
28. Laupacis A, Boysen G, Connolly S, Ezekowitz M, Hart R, James K, et al. Risk-factors for stroke and efficacy of antithrombotic therapy in atrial-fibrillation: Analysis of pooled data from 5 randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457.
29. Vidaillet H, Granada JF, Chyou PH, Maassen K, Ortiz M, Pulido JN, et al. A population-based study of mortality among patients with atrial fibrillation or futter. Am J Med 2002; 113: 365-370.
30. Granada J, Uribe W, Chyou PH, Maassen K, Vierkant R, Smith PN, et al. Incidence and predictors of atrial futter in the general population. J Am Coll Cardiol 2000; 36: 2242-2246.
31. Orejarena LA, Vidaillet H, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998; 31: 150-157.
32. Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular nodal reentry: Clinical, electrophysiological, and therapeutic considerations. Circulation 1993; 88: 282-295.
33. Denes P, Wu D, Dhingra R, Amat-y-Leon F, Wyndham C, Rosen KM. Dual atrioventricular nodal pathways: A common electro-physiological response. Br Heart J 1975; 37: 1069-1076.
34. Sano S, Komori S, Amano T, Kohno I, Ishihara T, Sawanobori T, et al. Prevalence of ventricular preexcitation in Japanese schoolchildren. Heart 1998; 79: 374-378.
35. Ng CT, Ong HY, Cheok C, Chua TSJ, Ching CK. Prevalence of electrocardiographic abnormalities in an unselected young male multi-ethnic Southeast Asian population undergoing pre-participa-tion cardiovascular screening: Results of the Singapore Armed Forces electrocardiogram and echocardiogram screening protocol. Europace 2012; 14: 1018-1024.
36. Munger TM, Packer DL, Hammill SC, Feldman BJ, Bailey KR, Ballard DJ, et al. A population study of the natural-history of Wolff-Parkinson-White syndrome in Olmsted county, Minnesota, 1953 - 1989. Circulation 1993; 87: 866-873.
37. Mond HG, Proclemer A. The 11th World Survey of Cardiac Pacing and Implantable Cardioverter-Defbrillators: Calendar year 2009. A World Society of Arrhythmia's Project. Pacing Clin Electrophysiol 2011; 34: 1013-1027.
38. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998; 98: 2334-2351.
39. Mehra R. Global public health problem of sudden cardiac death. J Electrocardiol 2007; 40: S118-S122.
40. Fishman GI, Chugh SS, DiMarco JP, Albert CM, Anderson ME, Bonow RO, et al. Sudden cardiac death prediction and prevention report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation 2010; 122: 2335-2348.
41. Tokashiki T, Muratani A, Kimura Y, Muratani H, Fukiyama K. Sudden death in the general population in Okinawa: Incidence and causes of death. Jpn Circ J 1999; 63: 37-42.
42. Hua W, Zhang LF, Wu YF, Liu XQ, Guo DS, Zhou HL, et al. Incidence of sudden cardiac death in China: Analysis of 4 regional populations. J Am Coll Cardiol 2009; 54: 1110-1118.
43. Tungsanga K, Sriboonlue P. Sudden unexplained death syndrome in Northeast Thailand. Int J Epidemiol 1993; 22: 81-87.
44. Gervacio-Domingo G, Punzalan FE, Amarillo ML, Dans A. Sudden unexplained death during sleep occurred commonly in the general population in the Philippines: A sub study of the national nutrition and health survey. J Clin Epidemiol 2007; 60: 567-571.
45. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104: 2158-2163.
46. Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993; 88: 2953-2961.
47. Nagata M, Ninomiya T, Doi Y, Hata J, Ikeda F, Mukai N, et al. Temporal trends in sudden unexpected death in a general population: The Hisayama study. Am Heart J 2013; 165: 932-938.
48. Aizawa Y, Chinushi M, Washizuka T. Indications for an implant-able cardioverter defbrillator (ICD). Intern Med 2004; 43: 360-367.
49. Skinner JR. Guidelines for the diagnosis and management of familial long QT syndrome. Heart Lung Circ 2007; 16: 22-24.
50. Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al. Prevalence of the congenital long-QT syndrome. Circulation 2009; 120: 1761-1767.
51. Earle N, Crawford J, Smith W, Hayes I, Shelling A, Hood M, et al. Community detection of long QT syndrome with a clinical registry: An alternative to ECG screening programs? Heart Rhythm 2013; 10: 233-238.
52. Uhm JS, Hwang IU, Oh YS, Choi MS, Jang SW, Shin WS, et al. Prevalence of electrocardiographic fndings suggestive of sudden cardiac death risk in 10,867 apparently healthy young Korean men. Pacing Clin Electrophysiol 2011; 34: 717-723.
53. Hayashi K, Fujino N, Uchiyama K, Ino H, Sakata K, Konno T, et al. Long QT syndrome and associated gene mutation carriers in Japanese children: Results from ECG screening examinations. Clin Sci 2009; 117: 415-424.
54. Mahida S, Hogarth AJ, Cowan C, Tayebjee MH, Graham LN, Pepper CB. Genetics of congenital and drug-induced long QT syndromes: Current evidence and future research perspectives. J Interv Card Electrophysiol 2013; 37: 9-19.
55. Horigome H, Nagashima M, Sumitomo N, Yoshinaga M, Ushinohama H, Iwamoto M, et al. Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life a nationwide questionnaire survey in Japan. Circ Arrhythmia Electrophysiol 2010; 3: 10-17.
56. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, et al. Infuence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med 1998; 339: 960-965.
57. Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 2008; 117: 2184-2191.
58. Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, et al. Mutation site-specifc differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: Multicenter study in Japan. J Am Coll Car-diol 2004; 44: 117-125.
59. Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S, et al. Risk for life-threatening cardiac events in patients with genotype-confrmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol 2010; 57: 51-59.
60. Barsheshet A, Goldenberg I, O-Uchi J, Moss AJ, Jons C, Shimizu W, et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events implications for mutation-specifc response to beta-blocker therapy in type 1 long-QT syndrome. Circulation 2012; 125: 1988-1996.
61. Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006; 296: 1249-1254.
62. Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, et al. Short QT syndrome: A familial cause of sudden death. Circulation 2003; 108: 965-970.
63. Funada A, Hayashi K, Ino H, Fujino N, Uchiyama K, Sakata K, et al. Assessment of QT intervals and prevalence of short QT syndrome in Japan. Clin Cardiol 2008; 31: 270-274.
64. Maury P, Extramiana F, Sbragia P, Giustetto C, Schimpf R, Duparc A, et al. Short QT syndrome: Update on a recent entity. Arch Car-diovasc Dis 2008; 101: 779-786.
65. Giustetto C, Schimpf R, Mazzanti A, Scrocco C, Maury P, Anttonen O, et al. Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 2011; 58: 587-595.
66. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97: 457-460.
67. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: Report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111: 659-670.
68. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: Report of the second consensus conference. Heart Rhythm 2005; 2: 429-440.
69. Gaw AC, Lee B, Gervacio-Domingo G, Antzelevitch C, Divinagracia R, Jocano F Jr. Unraveling the enigma of bangungut. Is sudden unexplained nocturnal death syndrome (SUNDs) in the Philippines a disease allelic to the Brugada syndrome? Philipp J Intern Med 2011; 49: 165-176.
70. Miyasaka Y, Tsuji H, Yamada K, Tokunaga S, Saito D, Imuro Y, et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol 2001; 38: 771-774.
71. Matsuo K, Akahoshi M, Nakashima E, Suyama A, Seto S, Hayano M, et al. The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: A population-based study of four decades. J Am Coll Cardiol 2001; 38: 765-770.
72. Atarashi H, Ogawa S, Harumi K, Sugimoto T, Inoue H, Murayama M, et al. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese registry of Brugada syndrome. J Am Coll Cardiol 2001; 37: 1916-1920.
73. Furuhashi M, Uno K, Tsuchihashi K, Nagahara D, Hyakukoku M, Ohtomo T, et al. Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population. Heart 2001; 86: 161-166.
74. Sakabe M, Fujiki A, Tani M, Nishida K, Mizumaki K, Inoue H. Proportion and prognosis of healthy people with coved or saddleback type ST segment elevation in the right precordial leads during 10 years follow-up. Eur Heart J 2003; 24: 1488-1493.
75. Hermida JS, Lemoine JL, Aoun FB, Jarry G, Rey JL, Quiret JC. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol 2000; 86: 91-94.
76. Junttila MJ, Raatikainen MJ, Karjalainen J, Kauma H, Kesaniemi YA, Huikuri HV. Prevalence and prognosis of subjects with Bru-gada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J 2004; 25: 874-878.
77. Lee C, Soni A, Tate RB, Cuddy TE. The incidence and prognosis of Brugada electrocardiographic pattern in the Manitoba follow-up study. Can J Cardiol 2005; 21: 1286-1290.
78. Ito H, Yano K, Chen R, He Q, Curb JD. The prevalence and prognosis of a Brugada-type electrocardiogram in a population of middle-aged Japanese-American men with follow-up of three decades. Am J Med Sci 2006; 331: 25-29.
79. Gallagher MM, Forleo GB, Behr ER, Magliano G, De Luca L, Morgia V, et al. Prevalence and significance of Brugada-type ECG in 12,012 apparently healthy European subjects. Int J Cardiol 2008; 130: 44-48.
80. Chen QY, Kirsch GE, Zhang DM, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic: Ventricular fibrillation. Nature 1998; 392: 293-296.
81. Hedley PL, Jorgensen P, Schlamowitz S, Moolman-Smook J, Kanters JK, Corfeld VA, et al. The genetic basis of Brugada syndrome: A mutation update. Hum Mutat 2009; 30: 1256-1266.
82. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Brignole M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000; 102: 2509-2515.
83. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocar-diographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002; 105: 73-78.
84. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al. Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002; 105: 1342-1347.
85. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation 2010; 121: 635-643.
86. Mok NS, Priori SG, Napolitano C, Chan KK, Bloise R, Chan HW, et al. Clinical profle and genetic basis of Brugada syndrome in the Chinese population. Hong Kong Med J 2004; 10: 32-37.
87. Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M, et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythmia Electrophysiol 2009; 2: 495-503.
88. Takagi M, Aonuma K, Sekiguchi Y, Yokoyama Y, Aihara N, Hiraoka M. The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: Multicenter study in Japan. Heart Rhythm 2013; 10: 533-539.
89. Antzelevitch C. Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Circ J 2012; 76: 1054-1065.
90. Haissaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008; 358: 2016-2023.
91. Noseworthy PA, Tikkanen JT, Porthan K, Oikarinen L, Pietila A, Harald K, et al. The early repolarization pattern in the general population: Clinical correlates and heritability. J Am Coll Cardiol 2011; 57: 2284-2289.
92. Tikkanen JT, Anttonen O, Junttila MJ, Aro AL, Kerola T, Rissanen HA, et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med 2009; 361: 2529-2537.
93. Chen K, Huang CX, Wang X, Tang YH, Okello E, Salim M, et al. Characteristic of the prevalence of J wave in apparently healthy Chinese adults. Arch Med Res 2008; 39: 232-235.
94. Haruta D, Matsuo K, Tsuneto A, Ichimaru S, Hida A, Sera N, et al. Incidence and prognostic value of early repolarization pattern in the 12-lead electrocardiogram. Circulation 2011; 123: 2931-2937.
95. Obeyesekere MN, Klein GJ, Nattel S, Leong-Sit P, Gula LJ, Skanes AC, et al. A clinical approach to early repolarization. Circulation 2013; 127: 1620-1629.
96. Naruse Y, Tada H, Harimura Y, Hayashi M, Noguchi Y, Sato A, et al. Early repolarization is an independent predictor of occurrences of ventricular fibrillation in the very early phase of acute myocar-dial infarction. Circ Arrhythmia Electrophysiol 2012; 5: 506-513.
97. Tikkanen JT, Junttila MJ, Anttonen O, Aro AL, Luttinen S, Kerola T, et al. Early repolarization: Electrocardiographic phenotypes associated with favorable long-term outcome. Circulation 2011; 123: 2666-2673.
98. Wu SH, Lin XX, Cheng YJ, Qiang CC, Zhang J. Early repolariza-tion pattern and risk for arrhythmia death: A meta-analysis. J Am Coll Cardiol 2013; 61: 645-650.
99. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: A 7-year follow-up of 21 patients. Circulation 1995; 91: 1512-1519.
100. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196-200.
101. Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in bedouin families from israel. Am J Hum Genet 2001; 69: 1378-1384.
102. Vega AL, Tester DJ, Ackerman MJ, Makielski JC. Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythmia Electrophysiol 2009; 2: 540-547.
103. Kawamura M, Ohno S, Naiki N, Nagaoka I, Dochi K, Wang Q, et al. Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan. Circ J 2013; 77: 1705-1713.
104. Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009; 119: 2426-2434.
105. Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K, et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999; 34: 2035-2042.
106. Tester DJ, Medeiros-Domingo A, Will ML, Haglund CM, Ackerman MJ. Cardiac channel molecular autopsy: Insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. Mayo Clin Proc 2012; 87: 524-539.
107. Nishio H, Suzuki K. Postmortem molecular analysis for fatal ar-rhythmogenic disease in sudden unexplained death. Leg Med (Tokyo) 2009; 11(Suppl 1): S119-S120.
108. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, et al. Catecholaminergic polymorphic ventricular tachycardia: Electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003; 89: 66-70.
109. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106: 69-74.